Dechra Pharmaceuticals PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Ian Page, was filed 15 Jan 2024.
Dechra Pharmaceuticals PLC: what insiders have been doing
Dechra Pharmaceuticals PLC is a listed company. Its directors and officers file their transactions with RNS (LSE). No insider at Dechra Pharmaceuticals PLC has published a filing in the past twelve months. The most recent one dates from 15 January 2024.
Our records for Dechra Pharmaceuticals PLC go back to 2016, with 10 purchases and no sales on the open market in total.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 028.8% of flowOutside a trading venueISIN GB0009633180RNS:5033432-9Canonical exit: 14 Apr 2024 (T+90)
- 021.8% of flowOutside a trading venueISIN GB0009633180RNS:5033432-1Canonical exit: 14 Apr 2024 (T+90)
- 0Outside a trading venueISIN GB0009633180RNS:5033432-8Canonical exit: 14 Apr 2024 (T+90)
- 071.2% of flowOutside a trading venueISIN GB0009633180RNS:5033432-11
- 0Outside a trading venueISIN GB0009633180RNS:5033432-4
- 078.2% of flowOutside a trading venueISIN GB0009633180RNS:5033432-5
- 0Outside a trading venueISIN GB0009633180RNS:5033432-7Canonical exit: 14 Apr 2024 (T+90)
- 0Outside a trading venueISIN GB0009633180RNS:5033432-3Canonical exit: 14 Apr 2024 (T+90)
- 0Outside a trading venueISIN GB0009633180RNS:5033432-6Canonical exit: 14 Apr 2024 (T+90)
- 0Outside a trading venueISIN GB0009633180RNS:5033432-0Canonical exit: 14 Apr 2024 (T+90)
- 0Outside a trading venueISIN GB0009633180RNS:5033432-2Canonical exit: 14 Apr 2024 (T+90)
- 0Outside a trading venueISIN GB0009633180RNS:5033432-10
- 0Outside a trading venueISIN GB0009633180RNS:4941051-2
- 0Outside a trading venueISIN GB0009633180RNS:4941051-1
- 0Outside a trading venueISIN GB0009633180RNS:4941051-0
- 0Outside a trading venueISIN GB0009633180RNS:4938033Canonical exit: 11 Jan 2024 (T+90)
- 431 sharesOutside a trading venueISIN GB0009633180FCA-NSM:4506682-1
- 330 sharesOutside a trading venueISIN GB0009633180FCA-NSM:4114079-1
- 926 sharesOutside a trading venueISIN GB0009633180FCA-NSM:3725047-0
- 1,197 sharesOutside a trading venueISIN GB0009633180FCA-NSM:LSE20180305094031_13554371_20200330111428001_27855-1
- 1,197 sharesOutside a trading venueISIN GB0009633180FCA-NSM:LSE20180305094031_13554371_20200330111428001_27855-0
- 20,000 shares@ £11.407100.0% of flowFCA-NSM:LSE20160606133414_012842837_20200330143602368_4459Canonical exit: 1 Sept 2016 (T+90)
22 of 22 declarations
About Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC is a pharmaceutical company focused on the development and marketing of products for pets and livestock. It is listed on the London Stock Exchange under the ticker XLON.
